Personalized Medicine Market is Expected to Reach USD 2,452.5 billion by 2022

Global Personalized Medicine market is expected to reach USD 2,452.5 billion by 2022; according to a new study by Grand View Research, Inc. Growing number of approved companion diagnostics and biomarkers have aided the development of advanced personalized diagnostic tests and enhanced the level of treatment monitoring for a range of complex diseases. A significant number of diagnostics and therapeutic products, which are currently under clinical development and investigational research, are associated with one or the other proteomic or genomic markers and fall under category of companion diagnostics. 
Personalized medical care and nutrition accounted for the largest share of the market in 2014 owing to, the presence of a significantly large consumer base, relatively less number of regulatory mandates, and the over-the-counter nature of retail nutrition products. This large share is also due to, the highly capital-intensive nature of implementation of healthcare information technology and telemedicine applications.

Global personalized medicine market, by product, 2012-2022 (USD Billion)

Further key findings from the study suggest:

• Personalized nutrition and wellness was the largest product segment of the market in 2014. Growing population considerably high market usage and high accessibility are amongst key factors accounting for its large share. Moreover, the core segments of this market viz., personalized medicine diagnostics and therapeutics are expected to grow at the fastest rate over the forecast period due to, ongoing technological advancements in genetic medicine.
• North America was the largest regional market in 2014, with revenue estimated at over USD 500.0 billion. Presence of sophisticated healthcare infrastructure, favorable government initiatives pertaining to cancer research, and the presence of high patient and practitioner awareness levels are some key drivers of this market.
• Asia Pacific is expected to witness lucrative growth of over 13.0% over the forecast period. The presence of a large population base, high market penetration of segments such as complementary and alternative medicine, growing collaborative initiatives between western and eastern market participants are some key factors expected to drive regional market growth over the forecast period.
• Key players of this market include GE Healthcare, Illumina Inc., Quest Diagnostics, Abbott Diagnostics, Affymetrix, and Bayer Healthcare. Large presence of biotechnology and pharmaceutical manufacturers is expected to keep the industry rivalry at high levels throughout the forecast period. Moreover, the presence of extensive R&D to capitalize on novel growth opportunities is expected to further intensify competition over the forecast period.

For the purpose of this study, Grand View Research has segmented the global personalized medicine market on the basis of product and region:

Global Personalized Medicine Product Outlook (Revenue, USD Billion, 2012 – 2022)

• PM Diagnostics
• Genetic Testing
• Direct-to-consumer Diagnostics
• Esoteric Lab Services
• Esoteric Lab Tests
• PM Therapeutics
• Pharmaceutical
• Genomic Medicine
• Medical Devices
• Personalized Medical Care
• Telemedicine
• Healthcare Information Technology
• Diseases Management
• Personalized Nutrition & Wellness
• Retail Nutrition
• Complementary Medicine
• Alternative Medicine

Personalized Medicine Regional Outlook (Revenue, USD Billion, 2012 – 2022)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• MEA
• South Africa

Request for free sample of "Personalized Medicine Market "